XML 34 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities    
Net income [1] $ 1,496.7 $ 1,194.6
Adjustments to reconcile net income to net cash provided by (used in) operating activities    
Depreciation and amortization of property and equipment [1] 114.9 106.9
Stock-based compensation expense [1] 135.3 110.6
Realized gains on dispositions of available-for-sale T. Rowe Price investment products [1]   (78.0)
Gains recognized upon transfer of an investment in a T. Rowe Price mutual fund from available-for-sale to held as trading [1]   (23.6)
Net gains recognized on investments [1] (106.2) (40.4)
Net investments in T. Rowe Price investment products to economically hedge supplemental savings plan liability [1] (14.4) (129.0)
Net change in securities held by consolidated T. Rowe Price investment products [1] (578.3) (1,210.5)
Other changes in assets and liabilities [1] 438.4 422.2
Net cash provided by (used in) operating activities [1] 1,486.4 352.8
Cash flows from investing activities    
Purchases of T. Rowe Price investment products [1] (1,118.7) (39.0)
Dispositions T. Rowe Price investment products [1] 343.6 295.8
Net cash of T. Rowe Price investment products on consolidation (deconsolidation) [1] (22.5) (46.0)
Additions to property and equipment [1] (121.5) (129.1)
Other investing activity [1] 88.7 (6.3)
Net cash provided by (used in) investing activities [1] (830.4) 75.4
Cash flows from financing activities    
Repurchases of common stock [1] (543.0) (456.7)
Common share issuances under stock-based compensation plans [1] 116.0 142.8
Dividends paid to common stockholders of T. Rowe Price Group [1] (522.3) (420.8)
Net subscriptions into consolidated T. Rowe Price investment products [1] 486.2 1,005.3
Net cash provided by (used in) financing activities [1] (463.1) 270.6
Effect of exchange rate changes on cash and cash equivalents of consolidated T. Rowe Price investment products [1] (2.4) 6.9
Net change in cash and cash equivalents during period [1] 190.5 705.7
Cash and cash equivalents at end of period, including $65.6 million at December 31, 2016, and $103.1 million at December 31, 2017, held by consolidated T. Rowe Price investment products [1] 2,005.8 1,270.5
Cash and cash equivalents at end of period, including $106.8 million at September 30, 2017, and $105.7 million at September 30, 2018, held by consolidated T. Rowe Price investment products [1] $ 2,196.3 $ 1,976.2
[1] See note 12 for supplementary consolidating cash flow statements.